Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Inventory Average: 2020-2025

Historic Inventory Average for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $6.7 million.

  • Harmony Biosciences Holdings' Inventory Average rose 6.00% to $6.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 6.00%. This contributed to the annual value of $6.3 million for FY2024, which is 22.20% up from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Inventory Average of $6.7 million as of Q3 2025, which was up 3.89% from $6.4 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Inventory Average's 5-year high stood at $7.1 million during Q4 2024, with a 5-year trough of $4.4 million in Q1 2021.
  • Moreover, its 3-year median value for Inventory Average was $5.8 million (2024), whereas its average is $5.9 million.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Inventory Average soared by 59.14% in 2021, and later dropped by 10.94% in 2022.
  • Over the past 5 years, Harmony Biosciences Holdings' Inventory Average (Quarterly) stood at $5.1 million in 2021, then declined by 6.58% to $4.7 million in 2022, then climbed by 13.52% to $5.4 million in 2023, then skyrocketed by 31.42% to $7.1 million in 2024, then increased by 6.00% to $6.7 million in 2025.
  • Its Inventory Average stands at $6.7 million for Q3 2025, versus $6.4 million for Q2 2025 and $6.9 million for Q1 2025.